Yoshitaka Inaba

5.3k total citations
197 papers, 3.1k citations indexed

About

Yoshitaka Inaba is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Yoshitaka Inaba has authored 197 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Hepatology, 85 papers in Pulmonary and Respiratory Medicine and 69 papers in Surgery. Recurrent topics in Yoshitaka Inaba's work include Hepatocellular Carcinoma Treatment and Prognosis (88 papers), Colorectal Cancer Treatments and Studies (23 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (20 papers). Yoshitaka Inaba is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (88 papers), Colorectal Cancer Treatments and Studies (23 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (20 papers). Yoshitaka Inaba collaborates with scholars based in Japan, United States and United Kingdom. Yoshitaka Inaba's co-authors include Yasuaki Arai, Takeshi Aramaki, Yozo Sato, Yoshito Takeuchi, Kiyoshi Matsueda, Hidekazu Yamaura, Takaaki Hasegawa, Toshihiro Tanaka, Masafumi Ikeda and Yasushi Yatabe and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Radiology.

In The Last Decade

Yoshitaka Inaba

178 papers receiving 3.1k citations

Peers

Countries citing papers authored by Yoshitaka Inaba

Since Specialization

Citations

This map shows the geographic impact of Yoshitaka Inaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshitaka Inaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshitaka Inaba more than expected).

Fields of papers citing papers by Yoshitaka Inaba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshitaka Inaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshitaka Inaba. The network helps show where Yoshitaka Inaba may publish in the future.

Co-authorship network of co-authors of Yoshitaka Inaba

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshitaka Inaba. A scholar is included among the top collaborators of Yoshitaka Inaba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshitaka Inaba. Yoshitaka Inaba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-Term Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in Real-World Clinical Practice 2025 ·Cancers ·Junji Furuse, Namiki Izumi, Kenta Motomura, Yoshitaka Inaba, Yoshio Katamura, Yasuteru Kondo, Kazuhisa Yabushita, (unknown), (unknown), Masatoshi Kudo	0
2	Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma 2025 ·BMC Cancer ·Yoshihisa Kodama, (unknown), Michihisa Moriguchi, Yoshitaka Inaba, Tatsuya Yamashita, Hideki Iwamoto, Makoto Ueno, Sadahisa Ogasawara, Teiji Kuzuya, Takahiro Kodama, Yozo Sato, Toshifumi Tada, Kaoru Tsuchiya, Hideyuki Nishiofuku, Koichiro Yamakado, Miyuki Sone, (unknown), Tetsuo Takehara, Tetsutaro Hamano, (unknown)	3
3	166P Outcomes by baseline liver function in EMERALD-1: A phase III, randomised, placebo (PBO)-controlled study of durvalumab (D) with or without bevacizumab (B) with transarterial chemoembolisation (TACE) in participants (pts) with embolisation-eligible unresectable hepatocellular carcinoma (uHCC) 2024 ·Annals of Oncology ·(unknown), Thomas Decaens, (unknown), Joseph P. Erinjeri, Riccardo Lencioni, (unknown), В. В. Бредер, Jeong Heo, Vincenzo Mazzaferro, Jung‐Won Park, (unknown), (unknown), Y. Xu, Yoshitaka Inaba, (unknown), (unknown), Cheryl L. McCoy, (unknown), Bruno Sangro	0
4	Radiofrequency Ablation in Patients with Interstitial Lung Disease and Lung Neoplasm: A Retrospective Multicenter Study 2024 ·Journal of Vascular and Interventional Radiology ·Akira Yamamoto, Takao Hiraki, (unknown), (unknown), (unknown), (unknown), Yoshitaka Tamura, Yoshitaka Inaba, Tae Iwasawa, Mayu Uka, (unknown), (unknown), Tomohisa Okuma, (unknown)	0
5	Basic Techniques and Technical Tips for Ultrasound-guided Needle Puncture 2024 ·PubMed ·Yozo Sato, Kiyoshi Matsueda, Yoshitaka Inaba	0
6	Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study 2023 ·Hepatology Research ·Naoya Kato, Masatoshi Kudo, Kaoru Tsuchiya, Atsushi Hagihara, Kazushi Numata, Hiroshi Aikata, Yoshitaka Inaba, Shunsuke Kondo, Kenta Motomura, Naohiro Okano, Masafumi Ikeda, Manabu Morimoto, Shingo Kuroda, Akiko Kimura	3
7	Skeletal Muscle Quality and Quantity Affect Prognosis after Neoadjuvant Chemotherapy with a Triple Regimen of Docetaxel/Cisplatin/5-FU in Patients with Esophageal Cancer 2023 ·Journal of Clinical Medicine ·(unknown), Masahiro Tajika, Tsutomu Tanaka, (unknown), Akihiro Takagi, Sachiyo Onishi, Tetsuya Abe, (unknown), (unknown), Yoshitaka Inaba, Kei Muro, Hiroki Kawashima, Yasumasa Niwa	1
8	609P The impact of surgical invasiveness on the efficacy of mFOLFOX6 in resected colorectal liver metastasis: An exploratory analysis of JCOG0603 2023 ·Annals of Oncology ·(unknown), Kozo Kataoka, Junki Mizusawa, (unknown), Yoshitaka Inaba, Masayuki Ohue, Koji Komori, Akio Shiomi, Manabu Shiozawa, Jun Watanabe, Takeshi Suto, Yusuke Kinugasa, Yasumasa Takii, Hiroyuki Bando, Takaya Kobatake, Masafumi Inomata, Katsuki Danno, Masaaki Ito, Hitoshi Ojima, Yukihide Kanemitsu	0
9	Interventional management for postoperative arterial bleeding in gastrointestinal surgery 2022 ·SHILAP Revista de lepidopterología ·Yozo Sato, Kiyoshi Matsueda, Marie Osawa, Yoshitaka Inaba, Yu Takahashi, Yosuke Inoue, Atsushi Oba, Yosuke Fukunaga, Yasuhiro Shimizu	0
10	Impact of the Ablative Margin on Local Tumor Progression after Radiofrequency Ablation for Lung Metastases from Colorectal Carcinoma: Supplementary Analysis of a Phase II Trial (MLCSG-0802) 2022 ·Journal of Vascular and Interventional Radiology ·Takaaki Hasegawa, Haruyuki Takaki, Hiroshi Kodama, Keitaro Matsuo, Takashi Yamanaka, Atsuhiro Nakatsuka, Motoshi Takao, Hideo Gobara, (unknown), Yoshitaka Inaba, Koichiro Yamakado	7
11	Detection rate of endoscopic ultrasound and computed tomography in diagnosing pancreatic neuroendocrine neoplasms including small lesions: A multicenter study 2022 ·Journal of Hepato-Biliary-Pancreatic Sciences ·Yusuke Kurita, Kazuo Hara, Noritoshi Kobayashi, Takamichi Kuwahara, Nobumasa Mizuno, Nozomi Okuno, Shin Haba, (unknown), Sho Hasegawa, Takamitsu Sato, Kunihiro Hosono, Itaru Endo, Yasuhiro Shimizu, Yasumasa Niwa, Daisuke Utsunomiya, Yoshitaka Inaba, Atsushi Nakajima, Kensuke Kubota, Yasushi Ichikawa	6
12	Effect of Body Composition Change during Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma 2022 ·Journal of Clinical Medicine ·Sachiyo Onishi, Masahiro Tajika, Tsutomu Tanaka, (unknown), (unknown), Tetsuya Abe, (unknown), (unknown), (unknown), Yoshitaka Inaba, Kei Muro, Masahito Shimizu, Yasumasa Niwa	4
13	Conventional or Drug-Eluting Beads? Randomized Controlled Study of Chemoembolization for Hepatocellular Carcinoma: JIVROSG-1302 2022 ·Liver Cancer ·Masafumi Ikeda, Yasuaki Arai, Yoshitaka Inaba, Toshihiro Tanaka, Shunsuke Sugawara, Yoshihisa Kodama, Takeshi Aramaki, Hiroshi Anai, Shinichi Morita, (unknown), Hiroshi Seki, Mikio Sato, Kenya Kamimura, (unknown), Masakatsu Tsurusaki, (unknown), Masaya Miyazaki, Tatsushi Kobayashi, Miyuki Sone	48
14	Three-year Survival Rate after Radiofrequency Ablation for Surgically Resectable Colorectal Lung Metastases: A Prospective Multicenter Study 2020 ·Radiology ·Takaaki Hasegawa, Haruyuki Takaki, Hiroshi Kodama, Takashi Yamanaka, Atsuhiro Nakatsuka, Yozo Sato, Motoshi Takao, (unknown), Ichiro Fukai, Toshio Kato, Toshiya Tokui, (unknown), (unknown), (unknown), Yoshitaka Inaba, Koichiro Yamakado	47
15	Prognostic Impact of Sarcopenic Obesity after Neoadjuvant Chemotherapy Followed by Surgery in Elderly Patients with Esophageal Squamous Cell Carcinoma 2020 ·Journal of Clinical Medicine ·Sachiyo Onishi, Masahiro Tajika, Tsutomu Tanaka, (unknown), Tetsuya Abe, (unknown), Takahiro Hosoi, Yoshitaka Inaba, Kei Muro, Masahito Shimizu, Yasumasa Niwa	25
16	Pre-existing pulmonary fibrosis is a risk factor for anti-PD-1-related pneumonitis in patients with non-small cell lung cancer: A retrospective analysis 2018 ·Lung Cancer ·Teppei Yamaguchi, Junichi Shimizu, Takaaki Hasegawa, Yoshitsugu Horio, Yoshitaka Inaba, Yasushi Yatabe, Toyoaki Hida	111
17	Prognosis of patients with intermediate-stage hepatocellular carcinomas based on the Child-Pugh score: subclassifying the intermediate stage (Barcelona Clinic Liver Cancer stage B) 2014 ·Japanese Journal of Radiology ·Koichiro Yamakado, Shiro Miyayama, Shozo Hirota, Kimiyoshi Mizunuma, Kenji Nakamura, Yoshitaka Inaba, Satoshi Yamamoto, Keitaro Matsuo, Norifumi Nishida, Takeshi Aramaki, Hiroshi Anai, (unknown), (unknown), Ken Watanabe, Taku Yasumoto, (unknown), Masato Yamaguchi	35
18	Lipiodol Lymphangiography and Selective Pleurodesis were Effective against Refractory Chylothorax after Salvage Esophagectomy 2014 ·The Japanese Journal of Gastroenterological Surgery ·(unknown), Tetsuya Abe, Norihisa Uemura, (unknown), (unknown), (unknown), Yoshitaka Inaba, Yasuhiro Shimizu, Masayuki Shinoda	1
19	Computed tomography of the head: clinical experience of the first 3000 scans with EMI scanner. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Yoshitaka Inaba, (unknown), (unknown)	1
20	[Significance of computed tomography in therapeutic diagnosis of brain tumors (author's transl)]. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), (unknown), K. Fujiwara, Koji Nishimoto, M Ohata, (unknown), Yoshitaka Inaba	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact